DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Amble Health alternatives: what else costs less or bills differently

As of November 20, 2026, Amble Health has no current month-to-month price that can be compared like for like ("Plans starting at $99 per month" without naming the drug; "No membership fees"), so the tables below list the programs that do print one.

Released · Last reviewed · how we verify

Tirzepatide: programs that print a comparable price

Amble Health cannot be placed on the like-for-like tirzepatide scale because its page shows no month-to-month figure that applies at the maintenance dose. These programs print a month-to-month, all-in tirzepatide price that applies at every dose or at the maintenance dose (read November 20, 2026).

Compounded tirzepatide programs with a comparable month-to-month price, sorted by a year’s cost (read November 20, 2026)
ProgramMonth to month, all-inBasisYear at that priceLowest printed rateRead
Collective$85.58per month$1,027$85.58 ($69 a month plus $199 a year)2026-11-20
Mondae$126per month$1,512$114 (6-month plan, $684)2026-11-20
NexLife$129per month$1,548$115 (12-month plan)2026-11-20
Eden$129per month$1,548$129 (every month)2026-11-20
Yucca Health$139per month$1,668$119 (12-month plan, $1,428 upfront)2026-11-20
Fifty 410$199per 28-day cycle$2,587$149.50 (8-week program at $299, not in all states)2026-11-20
Emerge Weight Loss$269per 28-day cycle$3,497$224 (2.5 mg, per 4 weeks)2026-11-20
OrderlyMeds$299per month$3,588$149 (2-month new-customer offer, $299)2026-11-20

Semaglutide: programs that print a comparable price

Amble Health cannot be placed on the like-for-like semaglutide scale because its page shows no month-to-month figure that applies at the maintenance dose. These programs print a month-to-month, all-in semaglutide price that applies at every dose or at the maintenance dose (read November 20, 2026).

Compounded semaglutide programs with a comparable month-to-month price, sorted by a year’s cost (read November 20, 2026)
ProgramMonth to month, all-inBasisYear at that priceLowest printed rateRead
Collective$75.58per month$907$75.58 ($59 a month plus $199 a year)2026-11-20
Mondae$87per month$1,044$69 (6-month plan, $414)2026-11-20
Yucca Health$89per month$1,068$69 (12-month plan, $828 upfront)2026-11-20
Eden$99per month$1,188$99 (every month)2026-11-20
NexLife$109per month$1,308$95 (12-month plan)2026-11-20
OrderlyMeds$149per month$1,788$74 (2-month new-customer offer, $149)2026-11-20
Fifty 410$199per 28-day cycle$2,587$199 (4-week program)2026-11-20
Noom Med$249per 28-day cycle$3,237$249 (per 4 weeks, billed every 12 weeks)2026-11-20

Brand alternatives

FDA-approved brand medication bought direct costs more: Zepbound vials from $299 at 2.5 mg to $449 a month at 7.5–15 mg with refills inside 45 days (LillyDirect, ladder carried from October 15), and Wegovy pens $349 a month (NovoCare, read November 20, 2026). Insurance coverage of a brand drug usually beats any cash price; see the insurance page.

Limitations

Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. Switching programs means a new prescriber review; ask the new program how it handles your current dose.

Frequently asked

What is the main alternative to Amble Health?

As of November 20, 2026, Amble Health has no current month-to-month price that can be compared like for like ("Plans starting at $99 per month" without naming the drug; "No membership fees"), so the tables below list the programs that do print one.

How are alternatives chosen here?

By the same basis for every program: the compounded month-to-month, all-in price at the maintenance dose, read on the program’s own page on November 20, 2026, turned into a year’s cost (12 months, or 13 four-week cycles). Programs that print only a starting-dose or coupon price are listed separately, because their regular cost cannot be confirmed.

Amble Health recordAll alternativesRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.